Companies covered: Medigus Ltd. (NASDAQ:MDGS), Profound Medical Corp. (CVE:PRN), iCAD, Inc. (NASDAQ:ICAD), EndoChoice Holdings, Inc. (NYSE:GI), NanoVibronix Inc. (NASDAQ:NAOV), Akers Biosciences Inc (NASDAQ:AKER), DexCom, Inc. (NASDAQ:DXCM), Nevro Corp. (NYSE:NVRO), ConforMIS Inc (NASDAQ:CFMS), Johnson & Johnson (NYSE:JNJ), Stryker Corporation (NYSE:SYK), Zimmer Biomet Holdings Inc. (NYSE:ZBH), Smith & Nephew SNATS, Inc. (NYSE:SNN), Medtronic, Inc. (NYSE:MDT), St. Jude Medical, Inc. (NYSE:STJ), Boston Scientific Corporation (NYSE:BSX), Intuitive Surgical, Inc. (NASDAQ:ISRG), TransEnterix, Inc. (AMEX:TRXC), Alphabet Inc (NASDAQ:GOOG)
